Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luigi Portella

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Seminars in Oncology|August 7, 2019
Ionizing radiation effects on the tumor microenvironmentLuigi Portella, Stefania Scala
Advances in Experimental Medicine and Biology|July 21, 2021
CXCL12 Signaling in the Tumor MicroenvironmentLuigi Portella, Anna Maria Bello, Stefania Scala
Molecular Diagnosis & Therapy|May 10, 2014
Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potentialGiuseppe Galletti, Luigi Portella, Scott T Tagawa, et al.
Chemical Biology & Drug Design|April 26, 2012
The N-terminal region of CXCL11 as structural template for CXCR3 molecular recognition: synthesis, conformational analysis, and binding studiesPasquale Palladino, Luigi Portella, Giovanni Colonna, et al.
Cancer Research|February 22, 2014
Androgen receptor splice variants determine taxane sensitivity in prostate cancerMaria Thadani-Mulero, Luigi Portella, Shihua Sun, et al.
Molecular Biosystems|August 12, 2015
Intrinsically disordered amphiphilic peptides as potential targets in drug delivery vehiclesMarian Vincenzi, Antonella Accardo, Susan Costantini, et al.
Scientific Reports|June 2, 2017
A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumorsSara Santagata, Luigi Portella, Maria Napolitano, et al.
International Journal of Molecular Sciences|June 2, 2015
Conformational ensembles explored dynamically from disordered peptides targeting chemokine receptor CXCR4Marian Vincenzi, Susan Costantini, Stefania Scala, et al.
Cancer Immunology, Immunotherapy : CII|March 9, 2012
Inhibition of stromal CXCR4 impairs development of lung metastasesCrescenzo D'Alterio, Antonio Barbieri, Luigi Portella, et al.
Journal of Medicinal Chemistry|March 10, 2018
Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer CellsDiego Brancaccio, Donatella Diana, Salvatore Di Maro, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Seminars in Oncology|August 7, 2019
Ionizing radiation effects on the tumor microenvironmentLuigi Portella, Stefania Scala
Advances in Experimental Medicine and Biology|July 21, 2021
CXCL12 Signaling in the Tumor MicroenvironmentLuigi Portella, Anna Maria Bello, Stefania Scala
Molecular Diagnosis & Therapy|May 10, 2014
Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potentialGiuseppe Galletti, Luigi Portella, Scott T Tagawa, et al.
Chemical Biology & Drug Design|April 26, 2012
The N-terminal region of CXCL11 as structural template for CXCR3 molecular recognition: synthesis, conformational analysis, and binding studiesPasquale Palladino, Luigi Portella, Giovanni Colonna, et al.
Cancer Research|February 22, 2014
Androgen receptor splice variants determine taxane sensitivity in prostate cancerMaria Thadani-Mulero, Luigi Portella, Shihua Sun, et al.
Molecular Biosystems|August 12, 2015
Intrinsically disordered amphiphilic peptides as potential targets in drug delivery vehiclesMarian Vincenzi, Antonella Accardo, Susan Costantini, et al.
Scientific Reports|June 2, 2017
A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumorsSara Santagata, Luigi Portella, Maria Napolitano, et al.
International Journal of Molecular Sciences|June 2, 2015
Conformational ensembles explored dynamically from disordered peptides targeting chemokine receptor CXCR4Marian Vincenzi, Susan Costantini, Stefania Scala, et al.
Cancer Immunology, Immunotherapy : CII|March 9, 2012
Inhibition of stromal CXCR4 impairs development of lung metastasesCrescenzo D'Alterio, Antonio Barbieri, Luigi Portella, et al.
Journal of Medicinal Chemistry|March 10, 2018
Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer CellsDiego Brancaccio, Donatella Diana, Salvatore Di Maro, et al.
Pageof 4